Terns Pharmaceuticals, Inc. — Director's Dealing 2022

Jun 22, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2022-06-16

Reporting Person: FELLOWS DAVID A (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-16	Stock Option (Right to Buy)	$1.82	A	32000.00	Acquired	2032-06-15	Common Stock (32000.00)	Direct

Footnotes

F1: The option will vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant.